ResMed
Financial ratios & Valuation

Forward Multiples (2026 – 2028)

202620272028
Price/Earnings ratio
30.9627.8327.01
Price/Sales ratio
7.727.256.72
Earnings per Share (EPS)
$9.16$10.19$10.5

Historical Multiples (2015 – 2024)

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 TTM Median
Valuation Ratios
Price/Earnings ratio
22.4325.1632.1546.8543.7744.5775.4939.2835.7226.9230.7744.57
Price/Sales ratio
4.714.825.326.316.799.3711.208.557.595.867.126.79
Price/Book Value ratio
4.985.235.617.188.5411.0912.419.117.765.656.5911.09
Price/Cash Flow ratio
20.6616.1826.5829.2838.5834.5448.6287.1946.2519.6123.7734.54
Price/Free Cash Flow ratio
25.4418.4632.1334.1046.4039.7957.78156.9357.3321.3625.4139.79
Price/Earnings Growth ratio
7.82N/A-8.96-5.391.560.85-3.120.622.442.00-38.610.85
Dividend Yield
1.98%1.89%1.69%1.34%1.19%0.81%0.63%0.80%0.80%1.02%0.86%0.86%
Profitability Indicator Ratios
Gross Profit Margin
60.24%58.00%58.14%58.20%58.95%58.09%57.52%56.57%55.78%56.67%57.20%58.09%
Operating Profit Margin
24.37%23.32%20.60%23.15%22.22%27.38%28.26%27.95%26.80%28.17%29.5%22.22%
Pretax Profit Margin
25.96%23.90%20.26%22.27%19.90%24.79%27.64%26.84%26.08%26.99%28.62%19.90%
Net Profit Margin
21.01%19.16%16.56%13.48%15.52%21.02%14.84%21.78%21.25%21.79%23.14%15.52%
Effective Tax Rate
19.04%19.82%18.25%39.46%22.02%15.19%46.30%18.84%18.52%19.27%19.12%19.12%
Return on Assets
16.15%10.81%9.86%10.30%9.84%13.55%10.03%15.29%13.29%14.85%15.40%9.84%
Return On Equity
22.23%20.79%17.46%15.32%19.52%24.89%16.44%23.19%21.73%20.98%23.22%19.52%
Return on Capital Employed
21.34%16.36%13.69%21.22%16.30%20.31%23.67%22.7%18.88%22.13%22.44%16.30%
Liquidity Ratios
Current Ratio
5.402.224.562.082.062.521.72N/AN/AN/A2.922.06
Quick Ratio
4.481.873.821.551.431.831.221.721.801.681.901.43
Cash ratio
2.681.142.280.360.260.760.320.390.300.260.470.26
Days of Sales Outstanding
78.8275.8479.5675.4374.0059.7570.1358.7560.9265.2261.5861.58
Days of Inventory outstanding
134.98106.09113.22100.27119.27122.79122.86174.74195.07147.84162.85119.27
Operating Cycle
213.80181.93192.78175.71193.27182.55193.00233.50256.00213.06224.43193.27
Days of Payables Outstanding
44.3543.7539.1434.6039.4739.9937.1037.4029.4642.7444.2239.47
Cash Conversion Cycle
169.45138.18153.64141.11153.79142.55155.90196.09226.53170.32180.21153.79
Debt Ratios
Debt Ratio
0.130.350.310.090.300.250.130.150.210.100.090.25
Debt Equity Ratio
0.180.690.550.130.610.470.220.230.350.150.130.47
Long-term Debt to Capitalization
0.150.340.350.110.370.310.180.180.250.120.110.31
Total Debt to Capitalization
0.150.400.350.120.380.320.180.190.260.130.110.32
Interest Coverage Ratio
70.8238.8916.1719.7517.5920.0338.03N/AN/AN/A37.5817.59
Cash Flow to Debt Ratio
1.270.460.381.790.360.681.120.440.471.912.120.36
Company Equity Multiplier
1.371.921.761.481.981.831.631.511.631.411.391.83
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
0.220.290.200.210.170.270.230.090.160.290.290.17
Free Cash Flow / Operating Cash Flow Ratio
0.810.870.820.850.830.860.840.550.800.910.930.83
Cash Flow Coverage Ratio
1.270.460.381.790.360.681.120.440.471.912.120.36
Short Term Coverage Ratio
N/A1.82N/A44.0438.2766.9261.3911.0521.7839.83145.5638.27
Dividend Payout Ratio
44.56%47.70%54.44%63.21%52.32%36.20%47.77%31.47%28.77%27.65%26.02%36.20%